GlassScriptPhysician profile
Vani Sharma
NPI 1336302868
$1,410.76
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $250 · 2021: $415 · 2022: $113 · 2023: $20.52 · 2024: $25.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $45.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $45.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $325.58 | 2021-2024 | Ubrelvy |
| Novo Nordisk INC | $194.84 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.15 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $93.80 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $88.97 | 2019-2020 | |
| Lilly USA, LLC | $85.02 | 2019-2021 | |
| Amarin Pharma, INC. | $81.48 | 2020-2021 | |
| Amgen INC. | $76.26 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $67.53 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $65.97 | 2019-2021 | |
| Pfizer INC. | $50.55 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.69 | 2019-2020 | |
| Celgene Corporation | $26.25 | 2019 | |
| Glaxosmithkline, LLC. | $25.38 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $17.15 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.64 | 2020 | |
| Allergan, INC. | $15.51 | 2020 | |
| Ironshore Pharmaceuticals INC. | $14.69 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.38 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $13.87 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vani Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.